Jeffrey LaRose, Chief Scientific Officer at HeartWare International, Inc. (HTWR), sold 3,072 shares at $91.12 ($281K) on 2013-12-23, disclosed to the SEC on 2013-12-24.
Scheduled sale ($281k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.63 | 999 | $92K | 32.6% |
| 2 | $92.32 | 200 | $18K | 6.6% |
| 3 | $91.12 | 1,673 | $152K | 54.3% |
| 4 | $91.59 | 200 | $18K | 6.5% |
| Total | $91.39 avg | 3,072 | $281K | 100% |
| Filing → |
| HTWR | SELL | 2016-02-09 | $20K | — | Filing → |
| HTWR | SELL | 2015-12-23 | $57K | — | Filing → |
| HTWR | SELL | 2015-02-26 | $30K | — | Filing → |